UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.__)
Filed by the Registrant  x                              Filed by a party other than the Registrant  ☐
Check the appropriate box:
 
Preliminary Proxy Statement
  
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  
Definitive Proxy Statement
  
x  
Definitive Additional Materials
  
Soliciting Material Pursuant to §240.14a-12
Evelo Biosciences, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)
Payment of Filing Fee (Check all boxes that apply):
xNo fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.





definitivematerials_pagex1.jpg






definitivematerials_pagex2.jpg

Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Evelo Biosciences Charts.
Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Evelo Biosciences Charts.